Product NDC: | 68012-309 |
Proprietary Name: | Uceris |
Non Proprietary Name: | BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
Active Ingredient(s): | 9 mg/1 & nbsp; BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68012-309 |
Labeler Name: | Santarus, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA203634 |
Marketing Category: | NDA |
Start Marketing Date: | 20130114 |
Package NDC: | 68012-309-30 |
Package Description: | 30 TABLET in 1 BOTTLE (68012-309-30) |
NDC Code | 68012-309-30 |
Proprietary Name | Uceris |
Package Description | 30 TABLET in 1 BOTTLE (68012-309-30) |
Product NDC | 68012-309 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130114 |
Marketing Category Name | NDA |
Labeler Name | Santarus, Inc |
Substance Name | BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
Strength Number | 9 |
Strength Unit | mg/1 |
Pharmaceutical Classes |